Genovis delivered a Q1 report broadly in line with our estimates, meeting our sales projections show...
Alcadon delivered Q1/26 adj. EBITA of SEK 25m, +15% y/y and 3% above our expectation.
* Return to high organic growth (+41% vs. ABG +29%) * Middle Eastern conflict behind more cautious F...
Nelly Group's Q1 report was soft, with net sales of SEK 243m, down 2% y/y and 5% below SEB.
Aspo Q1 figures were relatively close to estimates.
YIT’s Q1 results corresponded to our expectations, with revenue of EUR 399m (Evli EUR 410m) and adj.
We hosted a roadshow with MLP CEO Dr. Uwe Schroeder-Wildberg.
Stille delivered a Q1 ahead of our estimates across the board, with 19% organic growth and a 21.
Redeye comments on Addnode’s Q1 2026 report, which fell somewhat short of expectations at both the t...
Redeye updates its estimates and valuation after Indutrade’s Q1 2026 report.
Redeye updates its estimates and valuation after OEM’s Q1 2026 report.
Ahead of Suominen's Q1 report, we lower 2026E-27E comparable EBITDA by 16-28% owing to increasing ra...
Ahead of Xplora's Q1 report, we decrease our 2026-28 EBITDA estimates by 4-6%, owing to slightly low...
Redeye makes three model changes ahead of Catella's Q1 2026 results (8 May), leaving its investment ...
Duell announced today that it is taking further actions to improve NWC management.
Coor rapporterade ett starkt Q1-resultat som överträffade förväntningarna, drivet av hög lönsamhet i...
Investeringsportföljen minskade till 486,3 MUSD (-23,8% årsbasis) främst p.
Redeye retains its positive view of Carasent following the acquisition of Infosolutions.
Last week, NAGA reported preliminary Q1 figures that came in as a mixed bag with softer than expecte...
Net sales from continuing operations was in line with our expectation in Q1.
InvesteraMera ger en kommentar på Q1-rapporten från Hansa Biopharma.